Sign in to view content

Phase 1 Safety Study of Intravitreal (ITV) Anti-High Temperature Requirement A1 (aHtrA1), a Novel Serine Protease Inhibitor, in Patients With GA

William Z. Bridges, MD

Video
Published 2020

Related

Episode 199: Nov/Dec 2019 Retinal Physician Preview: New Pathways for Dry AMD
Jayanth Sridhar, MD
Member Podcasts
2019
The MOSAIC Study: A Clinical and Humanistic Burden of Illness Study of Patients With GA and Their Caregivers in the United States and Canada
Sophie Jane Bakri, MD
Annual Meeting Talks
2023
Preliminary Results from a First-in-human Phase I/II Gene Therapy Study (FOCUS) of Subretinally Delivered GT005, an Investigational AAV2 Vector, in Patients with Geographic Atrophy Secondary to Age-related Macular Degeneration
Jared S. Nielsen, MD, MBA
Updates from the Field
2022

Category: AMD-Non-Neovascular

See more